Skip to main content
Premium Trial:

Request an Annual Quote

Accelr8 Extends Microarray Slide Production for Schott Nexterion

NEW YORK, June 10 (GenomeWeb News) - Accelr8 Technology will manufacture two types of microarray slides using its surface chemistry for Schott Nexterion, Accelr8 said yesterday.


Under the agreement, which expires at the end of the year, Accelr8 will produce Nexterion Slide HS, using its OptiChem surface chemistry, and will continue to supply Nexterion Slide H exclusively to Schott.


Accelr8 has since October been manufacturing Slide HS, which has a streptavidin surface, and has exclusively produced Slide H for Schott since November. Schott may also obtain an exclusive manufacturing and distribution license for Slide HS from Accelr8 later this year.


Product revenues for Accelr8 from the agreement will total approximately $150,000 for the rest of the year, according to the company.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.